Treatment of Locally Advanced Melanoma by Isolated Limb Infusion with Cytotoxic Drugs
Author Information
Author(s): Hidde M. Kroon
Primary Institution: Melanoma Institute Australia
Hypothesis
Isolated limb infusion (ILI) can provide comparable response rates to isolated limb perfusion (ILP) while being less invasive.
Conclusion
Isolated limb infusion is a promising alternative to isolated limb perfusion for treating advanced melanoma and sarcoma, with comparable efficacy and reduced toxicity.
Supporting Evidence
- Isolated limb infusion has been performed over 400 times at the Melanoma Institute Australia.
- Complete response rates for melanoma after ILI are reported at 38%, with partial responses at 46%.
- ILI can prevent amputation in 76-94% of sarcoma patients.
Takeaway
Doctors can treat serious skin cancers in the arms or legs using a special method that is less painful and complicated than older methods.
Methodology
The study involved performing isolated limb infusion (ILI) on patients with advanced melanoma and sarcoma, monitoring response rates and side effects.
Potential Biases
Potential bias due to the retrospective nature of some studies and variability in treatment protocols.
Limitations
The results may vary due to differences in protocols and the experience of the medical teams involved.
Participant Demographics
Patients with advanced melanoma and sarcoma confined to a limb.
Statistical Information
P-Value
P = .012
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website